Kirby Miranda, van Beek Edwin J R, Seo Joon Beom, Biederer Juergen, Nakano Yasutaka, Coxson Harvey O, Parraga Grace
Department of Radiology, University of British Columbia, Vancouver, Canada; UBC James Hogg Research Center & The Institute of Heart and Lung Health, St. Paul's Hospital, Vancouver, Canada.
Clinical Research Imaging Centre, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Eur J Radiol. 2017 Jan;86:335-342. doi: 10.1016/j.ejrad.2016.08.022. Epub 2016 Aug 28.
While the recent development of quantitative imaging methods have led to their increased use in the diagnosis and management of many chronic diseases, medical imaging still plays a limited role in the management of chronic obstructive pulmonary disease (COPD). In this review we highlight three pulmonary imaging modalities: computed tomography (CT), magnetic resonance imaging (MRI) and optical coherence tomography (OCT) imaging and the COPD biomarkers that may be helpful for managing COPD patients. We discussed the current role imaging plays in COPD management as well as the potential role quantitative imaging will play by identifying imaging phenotypes to enable more effective COPD management and improved outcomes.
虽然定量成像方法的最新发展已使其在许多慢性疾病的诊断和管理中得到更多应用，但医学成像在慢性阻塞性肺疾病（COPD）的管理中仍发挥着有限的作用。在本综述中，我们重点介绍三种肺部成像模式：计算机断层扫描（CT）、磁共振成像（MRI）和光学相干断层扫描（OCT）成像，以及可能有助于管理COPD患者的COPD生物标志物。我们讨论了成像目前在COPD管理中所起的作用，以及定量成像通过识别成像表型以实现更有效的COPD管理和改善预后可能发挥的潜在作用。
